The Kable

The Kable

Share this post

The Kable
The Kable
💉 Valneva's Ixchiq the first approved chikungunya vaccine; Moderna, others leveraging mRNA magic; Takeda gets two FDA approvals
Copy link
Facebook
Email
Notes
More
Friday Kable

💉 Valneva's Ixchiq the first approved chikungunya vaccine; Moderna, others leveraging mRNA magic; Takeda gets two FDA approvals

#469 | A breakthrough in RA research; Improved T-cell therapies; Coca-Cola safe to drink in Croatia

Ria's avatar
Vinod's avatar
Ria
and
Vinod
Nov 10, 2023
∙ Paid

Share this post

The Kable
The Kable
💉 Valneva's Ixchiq the first approved chikungunya vaccine; Moderna, others leveraging mRNA magic; Takeda gets two FDA approvals
Copy link
Facebook
Email
Notes
More
1
Share

Hello, and welcome back to your favourite life sciences newsletter for the last time this week. Climate-resilient health systems are making recurring appearances in today’s edition. Our first story is an African perspective on approaches to enhance climate-resilient and low-carbon health systems.

Developing countries like South Africa have been pushing b…

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More